Henry Ford Cancer Institute Announce the Availability of LumaGEM® Molecular Breast Imaging (MBI) Machine
The new technology was made possible by philanthropic support and donations Gamma Medica, molecular breast imaging (MBI) technology, announced today that the Henry Ford Cancer Institute has installed Gamma Medica’s LumaGEM® Molecular Breast Imaging system, which is the first MBI machine in...
Gamma Medica Announces Pennsylvania’s First Clinical Installation of LumaGEM® Molecular Breast Imaging System at Einstein Medical Center Philadelphia
Secondary screening method significantly improves early cancer detection for women with dense breast tissue.
Gamma Medica Announces Installation at Leading Medical Facility, Mercy Medical Center in Long Island, the First Clinical LumaGEM® Molecular Breast Imaging Technology to New York
Gamma Medica, a leader in molecular breast imaging (MBI) technology, today announced that Mercy Medical Center a member of Catholic Health Services of Long Island has purchased and installed New York’s first clinical LumaGEM® Molecular Breast Imaging...